A explorative study to asses the prevalence of heavy metal level abnormalities in patient presenting with unexplained cytopenia/low risk to a tertiary care hospital in North India

Open label prospective trial to asses the prevalence of heavy metal levels in patients presenting with unexplained although heavy metal lebel abnormalities have been described in mds and in unexplained cytopenias. The prevalence of the same is not known. Some of the these patients undergo chemotherapy after diagnosis of MDS, through our study we want to establish the prevalence and also prevention from the potential harmful therapy